Back to News
Market Impact: 0.35

CAH Quantitative Stock Analysis

CAHNDAQ
Company FundamentalsAnalyst InsightsCapital Returns (Dividends / Buybacks)Derivatives & VolatilityMarket Technicals & FlowsInvestor Sentiment & PositioningHealthcare & Biotech
CAH Quantitative Stock Analysis

Cardinal Health Inc. (CAH) has achieved a 100% rating from Validea's Multi-Factor Investor model, which is based on Pim van Vliet's conservative factor investing strategy. This top score indicates strong fundamental and valuation alignment for the large-cap drug distributor with a methodology that prioritizes low volatility stocks exhibiting strong momentum and high net payout yields, suggesting significant interest for investors focused on risk-adjusted returns.

Analysis

Cardinal Health Inc. (CAH) has received a maximum 100% rating from Validea's Multi-Factor Investor model, which is based on Pim van Vliet's published strategy targeting low-volatility stocks with strong momentum and high net payout yields. This perfect score indicates a strong alignment between the company's fundamentals and a conservative, factor-based investment philosophy. As a large-cap stock in the Major Drugs industry, CAH successfully passed the model's criteria for Market Cap and Standard Deviation, underscoring its low-volatility profile. However, it is noteworthy that the stock received a 'Neutral' rating on both the 'Twelve Minus One Momentum' and 'Net Payout Yield' components. This suggests that the model's final 'Pass' rating is heavily weighted towards the security's low-risk characteristics, making it particularly appealing for investors focused on risk-adjusted returns, a conclusion supported by the report's strongly positive sentiment score of 0.85.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo